Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.99 | 14745880 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.95 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.42 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.88 | 16434500 |
MESH:D000380 |
Agranulocytosis |
|
Clozapine |
5.41 | 14617031 16160616 12649775 |
MESH:D001321 |
Autistic Disorder |
|
Haloperidol |
2.72 | 18080171 19368416 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.43 | 19483382 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
2.18 | 16273361 16202921 20065188 18855134 19103187 20544844 18821012 19289846 18997820 18351453 16818667 18425577 17440819 20005174 19244106 18629630 16873071 19142967 19066611 19155303 17049068 15565566 19200415 18984771 19487384 11161223 20859285 19115204 19059307 15668708 17242785 20135344 21152245 19221464 19288272 18815881 19084267 19410462 21138602 17261762 19011961 19189212 20390343 17893378 19189210 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.87 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
1.85 | 16924424 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.88 | 17572228 |
MESH:D002375 |
Catalepsy |
|
Haloperidol |
5.31 | 1977408 15215559 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
3.03 | 19176532 |
MESH:D003072 |
Cognition Disorders |
|
Clozapine |
5.32 | 17123785 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Haloperidol |
5.15 | 20210726 |
MESH:D003704 |
Dementia |
|
Haloperidol |
4.86 | 11575062 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.72 | 19031437 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.53 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Clozapine |
3.02 | 16402076 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.72 | 19279558 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Clozapine |
6.00 | 15331141 |
MESH:D050171 |
Dyslipidemias |
|
Clozapine |
4.38 | 16402076 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.76 | 12083418 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
3.87 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
3.21 | 19155303 17893378 20544844 16202921 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
8.63 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
8.63 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.39 | 16709447 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.92 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.58 | 19069698 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.69 | 20558911 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.35 | 18467677 16221962 19176532 19772884 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.45 | 20558911 |
MESH:D006948 |
Hyperkinesis |
|
Clozapine |
5.30 | 16046005 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
2.48 | 19457130 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.80 | 16306350 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
3.27 | 18625569 |
MESH:D008064 |
Lipidoses |
|
Clozapine |
8.73 | 17567588 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
8.73 | 17567588 15342952 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.39 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
2.39 | 18564211 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
4.73 | 15890375 20007298 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
4.73 | 16684651 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
1.74 | 18625569 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
4.15 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
2.79 | 19196723 19196722 16827153 14580682 11731420 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.99 | 19453300 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
1.91 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.58 | 15990972 |
MESH:D001523 |
Mental Disorders |
|
Clozapine |
9.71 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Haloperidol |
9.71 | 16856516 |
MESH:D024821 |
Metabolic Syndrome X |
|
Clozapine |
4.65 | 19142101 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.86 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.24 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.16 | 16411023 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.64 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.59 | 19410462 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.06 | 17405874 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.44 | 19200415 19196722 19189210 |
MESH:D009765 |
Obesity |
|
Clozapine |
4.89 | 18515891 19142110 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.89 | 20558911 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
3.10 | 15067354 |
MESH:D011595 |
Psychomotor Agitation |
|
Haloperidol |
5.31 | 11575062 |
MESH:D011618 |
Psychotic Disorders |
|
Clozapine |
9.81 | 15331141 |
MESH:D011618 |
Psychotic Disorders |
|
Haloperidol |
9.81 | 11575062 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.50 | 19058328 |
MESH:D012559 |
Schizophrenia |
|
Clozapine |
4.21 | 17726453 18855531 19369910 16141801 17123785 20107430 20452607 20521320 20521326 20168265 20580759 17667964 11151749 11763009 18806925 |
MESH:D012559 |
Schizophrenia |
|
Haloperidol |
4.21 | 19369910 18513383 20107430 1830565 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
4.74 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.43 | 19457130 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Haloperidol |
5.04 | 20210726 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
2.44 | 16712894 8653321 17572228 |
MESH:D015430 |
Weight Gain |
|
Clozapine |
4.72 | 16402076 17502770 20521320 20107430 20564506 16141801 |
MESH:D015431 |
Weight Loss |
|
Clozapine |
5.47 | 17933447 |